Efficacy of immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma and predictive potential of mutated TP53. Wu M, Zhou N, Guan M, Wang Y, et al. Lung Cancer 2025;199:108068.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu M, Zhou N, Guan M, Wang Y, et al. Efficacy of immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma and predictive potential of mutated TP53. Lung Cancer 2025;199:108068.
PMID: 39736248